Atlas Trials

An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic(PK)Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Clinical trial NCT05788159 · UNKNOWN

Trial details

NCT number
NCT05788159
Sponsor
Overseas Pharmaceuticals, Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2023-04-01
Primary completion
2023-06-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.